EXOSOME DIAGNOSTICS
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.
EXOSOME DIAGNOSTICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
2008-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.exosomedx.com
Total Employee:
101+
Status:
Active
Contact:
1(617) 588-0500
Email Addresses:
[email protected]
Total Funding:
112.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
AltheaDx
AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Exosome Diagnostics
btov Partners
btov Partners investment in Series C - Exosome Diagnostics
CD-Venture
CD-Venture investment in Series C - Exosome Diagnostics
Blue Ridge Capital
Blue Ridge Capital investment in Series C - Exosome Diagnostics
NGN Capital
NGN Capital investment in Series C - Exosome Diagnostics
Tiger Infrastructure Partners
Tiger Infrastructure Partners investment in Series C - Exosome Diagnostics
Arcus Ventures
Arcus Ventures investment in Series C - Exosome Diagnostics
Tiger Management Corporation
Tiger Management Corporation investment in Series B - Exosome Diagnostics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Exosome Diagnostics
Arcus Ventures
Arcus Ventures investment in Series B - Exosome Diagnostics
Official Site Inspections
http://www.exosomedx.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.23 K
- Host name: a184-27-6-158.deploy.static.akamaitechnologies.com
- IP address: 184.27.6.158
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Exosome Diagnostics"
Exosome Diagnostics - Crunchbase Company Profile
Organization. Exosome Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 1(617) 588-0500; Exosome …See details»
Management Team | Bio-Techne Exosome
View leadership members in the organization. Skip to main content Top navigation. GSA Award; For Veterans; HCP Portal; Pay My Bill Online; Contact Us +1 844 396 7663; Search ...See details»
ExosomeDx and ZERO - The End of Prostate Cancer
Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer. ZERO advances research, …See details»
Exosome Diagnostics, a Bio-Techne brand | LinkedIn
Exosome Diagnostics, a Bio-Techne brand Biotechnology Research Waltham, MA 7,882 followers ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide ...See details»
Exosomes—the next frontier in biomarker discovery and diagnostics
ExosomeDx harnesses biological information from exosomes for biomarker discovery and diagnostic development. The company’s pipeline of products includes the ExoDx Prostate test, …See details»
Exosome Diagnostics Announces Launch of ExoDx® …
Sep 8, 2016 World’s First and Only Test Analyzing Genetic Information from Exosomes Via a Simple Urine Collection Requiring No Digital Rectal Exam Potential to Avoid Over One Million Unnecessary Prostate Biopsies Each Year …See details»
Taking Charge of Your Prostate Health - ExosomeDx
Online at exosomedx.com for more information. 16 Exosome Diagnostics was founded in 2008 by Johan Skog, PhD after a discovery that exosomes carry RNA biomarkers that can be used …See details»
ExoDx prostate test as a predictor of outcomes of high-grade …
May 16, 2023 Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI) score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of …See details»
The Role of the ExoDx Prostate Test in Early Detection …
Oct 26, 2021 Prostate cancer is the second leading cause of cancer in men globally, with more than 1 million new cases and 300,000 deaths attributed to this disease each year. 1 In 2021, an estimated 248,530 new cases of prostate …See details»
Press Releases: ExosomeDx
Feb 11, 2021 Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of …See details»
Exosome Dx Enters Partnership with Takeda - Business Wire
Jun 30, 2016 Exosome Diagnostics, Inc., the world’s only provider of an exosome liquid biopsy platform to monitor disease biomarkers in patient blood, with the goaSee details»
ExoDxâ„¢ Prostate Test - A Solution to Address Fear of the Prostate ...
Learn more: https://www.exosomedx.com/ Recent findings from a real-world clinical study underscore how EPI supports clinical decision making and motivate som...See details»
ExosomeDx - YouTube
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decision.Visit our website: https://www.exosom...See details»
Exosome-based Urine Test for High-grade Prostate Cancer
Dec 29, 2020 For men who have an elevated prostate-specific antigen (PSA) score on initial screening, poor compliance with physician recommended-biopsy is a common issue.See details»
ExoDxâ„¢ Prostate Test: At-Home Collection Kit - ExosomeDx
For additional assistance, our ExosomeDx Client Services Team is available Monday-Friday to answer questions about individual coverage at 617-588-0500. (844) 396-7663 …See details»
Exosome-based Genomic Testing improves Early Detection of …
Nov 16, 2023 Early detection, diagnosis, and treatment of prostate cancer have significantly reduced the mortality of this disease. However, the inherent limitations of PSA (prostate …See details»
The ExoDx Healthcare Provider Guide - ExosomeDx
Interpreting the ExoDx â„¢ Prostate Test Score The ExoDx Prostate Test score ranges from 0 to 100 with a cut point at 15.6. Score ranges are proportional to increased likelihood for HGPCa.See details»
Getting Started with the ExoDx Prostate Test - YouTube
Leveraging the power of exosomes to determine risk for clinically significant prostate cancer with an At-Home Collection Kit.Learn More: https://www.exosomed...See details»
What Are Exosomes | Prostate Cancer Detection
Exosomes are small double lipid membrane vesicles (typically 30-200 nm in diameter) that are secreted from all cells. Exosomes encapsulate a portion of the parent cell cytoplasm and are …See details»